Table 1.
Patients who did not fill the questionnaires | Patients who filled the questionnaires | p-value | |
---|---|---|---|
N | 74 | 109 | - |
Gender Male: Female | 60:14 | 92:17 | 0.55 |
Age (years)a | 63 (54–70) | 61 (53–68) | 0.35 |
Histotype:b | 0.75 | ||
Adenocarcinoma | 49 (66.2) | 75 (69.4) | |
Squamous cell carcinoma | 25 (33.8) | 33 (30.6) | |
Tumour site: | 0.08 | ||
Cervical oesophagus | 4 (5.4) | 6 (5.5) | |
Thoracic oesophagus | 19 (26.7) | 14 (12.8) | |
Oesophago-gastric junction | 51 (68.9) | 89 (81.7) | |
Neoadjuvant therapy: yes | 51 (68.9) | 90 (82.6) | 0.05 |
Hospital stay (days)a | 14 (13–20) | 19 (17–24) | <0.0001 |
Pathological stagec | 0.16 | ||
0 | 8 (10.8) | 25 (23.0) | |
I | 18 (24.3) | 19 (17.4) | |
II | 18 (24.3) | 24 (22.0) | |
III | 29 (39.2) | 36 (33.0) | |
IV | 1 (1.4) | 5 (4.6) | |
Post-operative morbidity | 22 (29.7) | 29 (26.6) | 0.74 |
Type of post-operative complications: | |||
Anastomotic leak | 6 | 8 | |
Pulmonary | 4 | 17 | |
Cardiac | 7 | 9 | |
Dysphonia | 0 | 3 | |
Urinary | 3 | 4 | |
Bleeding | 3 | 1 | |
Sepsis | 0 | 1 | |
Chylothorax | 1 | 0 | |
Diaframmatic hernia | 0 | 1 | |
Deep venous thrombosis | 0 | 1 | |
Pyloric stenosis | 1 | 0 | - |
Data expressed as n (%) or amedian (IQR)
bOther histotype in one patient
cPathological stage is ypstage for patients who received neoadjuvant therapy and pstage for patients who did not